Novel soluble HLA-A2/MELAN-A complexes selectively stain a differentiation defective subpopulation of CD8+ T cells in patients with melanoma

Philippe Guillaume, Petra Baumgaertner, Laurence Neff, Nathalie Rufer, Peter Wettstein, Daniel E. Speiser, Immanuel F. Luescher

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Multimeric MHC I-peptide complexes containing phycoerythrin-streptavidin are widely used to detect and investigate antigenspecific CD8+ (and CD4+) T cells. Because such reagents are heterogeneous, we compared their binding characteristics with those of monodisperse dimeric, tetrameric and octameric complexes containing linkers of variable length and flexibility on Melan-A-specific CD8+ T cell clones and peripheral blood mononuclear cells (PBMC) from HLA-A*0201 + melanoma patients. Striking binding differences were observed for different defined A2/Melan-A 26-35 complexes on T cells depending on their differentiation stage. In particular, short dimeric but not octameric A2/Melan-A 26-35 complexes selectively and avidly stained incompletely differentiated effector-memory T cells clones and populations expressing CD27 and CD28 and low levels of cytolytic mediators (granzymes and perforin). This subpopulation was found in PBMC from all six melanoma patients analyzed and proliferated on peptide stimulation with only modest phenotypic changes. By contrast influenza matrix 58-66 -specific CD8+ PBMC from nine HLA-A*0201 + healthy donors were efficiently stained by A2/Flu matrix 58-61 multimers, but not dimer and upon peptide stimulation proliferated and differentiated from memory into effector T cells. Thus PBMC from melanoma patients contain a differentiation defective sub-population of Melan-A-specific CD8+ T cells that can be selectively and efficiently stained by short dimeric A2/Melan- A 26-35 complexes, which makes them directly accessible for longitudinal monitoring and further investigation.

Original languageEnglish (US)
Pages (from-to)910-923
Number of pages14
JournalInternational Journal of Cancer
Volume127
Issue number4
DOIs
StatePublished - Aug 15 2010

Fingerprint

HLA-A2 Antigen
MART-1 Antigen
Melanoma
Coloring Agents
T-Lymphocytes
varespladib methyl
Blood Cells
Peptides
Clone Cells
Phycoerythrin
Granzymes
Perforin
Streptavidin
Human Influenza
Population
Tissue Donors

Keywords

  • CD8
  • Flow cytometry
  • Melanoma
  • T cell
  • Tetramer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Novel soluble HLA-A2/MELAN-A complexes selectively stain a differentiation defective subpopulation of CD8+ T cells in patients with melanoma. / Guillaume, Philippe; Baumgaertner, Petra; Neff, Laurence; Rufer, Nathalie; Wettstein, Peter; Speiser, Daniel E.; Luescher, Immanuel F.

In: International Journal of Cancer, Vol. 127, No. 4, 15.08.2010, p. 910-923.

Research output: Contribution to journalArticle

Guillaume, Philippe ; Baumgaertner, Petra ; Neff, Laurence ; Rufer, Nathalie ; Wettstein, Peter ; Speiser, Daniel E. ; Luescher, Immanuel F. / Novel soluble HLA-A2/MELAN-A complexes selectively stain a differentiation defective subpopulation of CD8+ T cells in patients with melanoma. In: International Journal of Cancer. 2010 ; Vol. 127, No. 4. pp. 910-923.
@article{1a634cd6a30b400a9c359d353c11f839,
title = "Novel soluble HLA-A2/MELAN-A complexes selectively stain a differentiation defective subpopulation of CD8+ T cells in patients with melanoma",
abstract = "Multimeric MHC I-peptide complexes containing phycoerythrin-streptavidin are widely used to detect and investigate antigenspecific CD8+ (and CD4+) T cells. Because such reagents are heterogeneous, we compared their binding characteristics with those of monodisperse dimeric, tetrameric and octameric complexes containing linkers of variable length and flexibility on Melan-A-specific CD8+ T cell clones and peripheral blood mononuclear cells (PBMC) from HLA-A*0201 + melanoma patients. Striking binding differences were observed for different defined A2/Melan-A 26-35 complexes on T cells depending on their differentiation stage. In particular, short dimeric but not octameric A2/Melan-A 26-35 complexes selectively and avidly stained incompletely differentiated effector-memory T cells clones and populations expressing CD27 and CD28 and low levels of cytolytic mediators (granzymes and perforin). This subpopulation was found in PBMC from all six melanoma patients analyzed and proliferated on peptide stimulation with only modest phenotypic changes. By contrast influenza matrix 58-66 -specific CD8+ PBMC from nine HLA-A*0201 + healthy donors were efficiently stained by A2/Flu matrix 58-61 multimers, but not dimer and upon peptide stimulation proliferated and differentiated from memory into effector T cells. Thus PBMC from melanoma patients contain a differentiation defective sub-population of Melan-A-specific CD8+ T cells that can be selectively and efficiently stained by short dimeric A2/Melan- A 26-35 complexes, which makes them directly accessible for longitudinal monitoring and further investigation.",
keywords = "CD8, Flow cytometry, Melanoma, T cell, Tetramer",
author = "Philippe Guillaume and Petra Baumgaertner and Laurence Neff and Nathalie Rufer and Peter Wettstein and Speiser, {Daniel E.} and Luescher, {Immanuel F.}",
year = "2010",
month = "8",
day = "15",
doi = "10.1002/ijc.25099",
language = "English (US)",
volume = "127",
pages = "910--923",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Novel soluble HLA-A2/MELAN-A complexes selectively stain a differentiation defective subpopulation of CD8+ T cells in patients with melanoma

AU - Guillaume, Philippe

AU - Baumgaertner, Petra

AU - Neff, Laurence

AU - Rufer, Nathalie

AU - Wettstein, Peter

AU - Speiser, Daniel E.

AU - Luescher, Immanuel F.

PY - 2010/8/15

Y1 - 2010/8/15

N2 - Multimeric MHC I-peptide complexes containing phycoerythrin-streptavidin are widely used to detect and investigate antigenspecific CD8+ (and CD4+) T cells. Because such reagents are heterogeneous, we compared their binding characteristics with those of monodisperse dimeric, tetrameric and octameric complexes containing linkers of variable length and flexibility on Melan-A-specific CD8+ T cell clones and peripheral blood mononuclear cells (PBMC) from HLA-A*0201 + melanoma patients. Striking binding differences were observed for different defined A2/Melan-A 26-35 complexes on T cells depending on their differentiation stage. In particular, short dimeric but not octameric A2/Melan-A 26-35 complexes selectively and avidly stained incompletely differentiated effector-memory T cells clones and populations expressing CD27 and CD28 and low levels of cytolytic mediators (granzymes and perforin). This subpopulation was found in PBMC from all six melanoma patients analyzed and proliferated on peptide stimulation with only modest phenotypic changes. By contrast influenza matrix 58-66 -specific CD8+ PBMC from nine HLA-A*0201 + healthy donors were efficiently stained by A2/Flu matrix 58-61 multimers, but not dimer and upon peptide stimulation proliferated and differentiated from memory into effector T cells. Thus PBMC from melanoma patients contain a differentiation defective sub-population of Melan-A-specific CD8+ T cells that can be selectively and efficiently stained by short dimeric A2/Melan- A 26-35 complexes, which makes them directly accessible for longitudinal monitoring and further investigation.

AB - Multimeric MHC I-peptide complexes containing phycoerythrin-streptavidin are widely used to detect and investigate antigenspecific CD8+ (and CD4+) T cells. Because such reagents are heterogeneous, we compared their binding characteristics with those of monodisperse dimeric, tetrameric and octameric complexes containing linkers of variable length and flexibility on Melan-A-specific CD8+ T cell clones and peripheral blood mononuclear cells (PBMC) from HLA-A*0201 + melanoma patients. Striking binding differences were observed for different defined A2/Melan-A 26-35 complexes on T cells depending on their differentiation stage. In particular, short dimeric but not octameric A2/Melan-A 26-35 complexes selectively and avidly stained incompletely differentiated effector-memory T cells clones and populations expressing CD27 and CD28 and low levels of cytolytic mediators (granzymes and perforin). This subpopulation was found in PBMC from all six melanoma patients analyzed and proliferated on peptide stimulation with only modest phenotypic changes. By contrast influenza matrix 58-66 -specific CD8+ PBMC from nine HLA-A*0201 + healthy donors were efficiently stained by A2/Flu matrix 58-61 multimers, but not dimer and upon peptide stimulation proliferated and differentiated from memory into effector T cells. Thus PBMC from melanoma patients contain a differentiation defective sub-population of Melan-A-specific CD8+ T cells that can be selectively and efficiently stained by short dimeric A2/Melan- A 26-35 complexes, which makes them directly accessible for longitudinal monitoring and further investigation.

KW - CD8

KW - Flow cytometry

KW - Melanoma

KW - T cell

KW - Tetramer

UR - http://www.scopus.com/inward/record.url?scp=77954742812&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954742812&partnerID=8YFLogxK

U2 - 10.1002/ijc.25099

DO - 10.1002/ijc.25099

M3 - Article

C2 - 19998338

AN - SCOPUS:77954742812

VL - 127

SP - 910

EP - 923

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 4

ER -